Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Immunostimulating whole plant product undergoes clinical trials on AIDS patients

June 7, 1996

NSC-158393: Promising candidate for development as anti-AIDS drug

June 7, 1996

Unimed announces licensing agreement on its testosterone products

May 31, 1996

NSC-645793 and NSC-651016: Anti-HIV agents with potential as clinical candidates

May 31, 1996

Marketing agreement for trimetrexate glucuronate announced

May 31, 1996

European patent covering lamivudine issued

May 31, 1996

Positive results on cidofovir topical gel

May 31, 1996

Ritonavir granted scientific approval from CPMP

May 31, 1996

Crixivan pediatric formulation in development

May 24, 1996

Adefovir dipivoxil to enter phase II/III in mid-1996

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...